Literature DB >> 22345593

Critical review of mouse models of venous thrombosis.

Jose A Diaz1, Andrea T Obi, Daniel D Myers, Shirley K Wrobleski, Peter K Henke, Nigel Mackman, Thomas W Wakefield.   

Abstract

Deep vein thrombosis and pulmonary embolism are a significant health care concern, representing a major source of mortality and morbidity. In order to understand the pathophysiology of thrombogenesis and thrombus resolution, animal models are necessary. Mouse models of venous thrombosis contribute to our understanding of the initiation, propagation, and resolution of venous thrombus, as well as allow for the evaluation of new pharmaceutical approaches to prophylaxis and treatment of deep vein thrombosis. In this work we review the ferric chloride model, the inferior vena cava ligation model, the inferior vena cava stenosis models, and the electrolytic inferior vena cava model and compare their advantages and disadvantages.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345593      PMCID: PMC3292052          DOI: 10.1161/ATVBAHA.111.244608

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  54 in total

1.  von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.

Authors:  Anil K Chauhan; Janka Kisucka; Colin B Lamb; Wolfgang Bergmeier; Denisa D Wagner
Journal:  Blood       Date:  2006-11-21       Impact factor: 22.113

2.  Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism.

Authors:  Rolando E Rumbaut; Ricardo V Bellera; Jaspreet K Randhawa; Corie N Shrimpton; Swapan K Dasgupta; Jing-Fei Dong; Alan R Burns
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-11       Impact factor: 4.733

3.  Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.

Authors:  Daniel D Myers; Shirley K Wrobleski; Chris Longo; Patricia W Bedard; Neelu Kaila; George D Shaw; Frank J Londy; Suzan E Rohrer; Beverly A Fex; Paul J Zajkowski; Thomas R Meier; Angela E Hawley; Diana M Farris; Nicole E Ballard; Peter K Henke; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

Review 4.  Mechanisms of venous thrombosis and resolution.

Authors:  Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03       Impact factor: 8.311

5.  Call to action to prevent venous thromboembolism.

Authors:  Thomas W Wakefield; Robert B McLafferty; Joann M Lohr; Joseph A Caprini; David L Gillespie; Marc A Passman
Journal:  J Vasc Surg       Date:  2009-06       Impact factor: 4.268

6.  Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.

Authors:  Thomas R Meier; Daniel D Myers; Shirley K Wrobleski; Paul J Zajkowski; Angela E Hawley; Patricia W Bedard; Nicole E Ballard; Frank J Londy; Neelu Kaila; George P Vlasuk; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

7.  Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats.

Authors:  Ji Zhou; Linda May; Peng Liao; Peter L Gross; Jeffrey I Weitz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-03-05       Impact factor: 8.311

8.  Engineered human soluble calcium-activated nucleotidase inhibits coagulation in vitro and thrombosis in vivo.

Authors:  Mingyan Yang; Terence L Kirley
Journal:  Thromb Res       Date:  2008-01-28       Impact factor: 3.944

9.  The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis.

Authors:  Yang Buyue; Herbert C Whinna; John P Sheehan
Journal:  Blood       Date:  2008-07-22       Impact factor: 22.113

10.  Systemic antithrombotic effects of ADAMTS13.

Authors:  Anil K Chauhan; David G Motto; Colin B Lamb; Wolfgang Bergmeier; Michael Dockal; Barbara Plaimauer; Friedrich Scheiflinger; David Ginsburg; Denisa D Wagner
Journal:  J Exp Med       Date:  2006-03-13       Impact factor: 14.307

View more
  98 in total

1.  AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis.

Authors:  Wanmu Xie; Lin Zhang; Wei Luo; Zhenguo Zhai; Chen Wang; Ying H Shen
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

2.  Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography.

Authors:  Ryan N Rys; Mark D Blostein; Catherine A Lemarié
Journal:  J Vis Exp       Date:  2018-04-13       Impact factor: 1.355

Review 3.  Mouse models of cancer-associated thrombosis.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Thromb Res       Date:  2017-12-29       Impact factor: 3.944

4.  Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury.

Authors:  Nicholas A Dewyer; Osama M El-Sayed; Catherine E Luke; Megan Elfline; Nicolai Kittan; Ron Allen; Adriana Laser; Carson Oostra; Anthony Comerota; Cory Hogaboam; Steven L Kunkel; Peter K Henke
Journal:  Thromb Haemost       Date:  2015-07-16       Impact factor: 5.249

5.  Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Authors:  Takuma Fukunishi; Cameron A Best; Chin Siang Ong; Tyler Groehl; James Reinhardt; Tai Yi; Hideki Miyachi; Huaitao Zhang; Toshiharu Shinoka; Christopher K Breuer; Jed Johnson; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2017-06-13       Impact factor: 3.845

Review 6.  Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology.

Authors:  Allan K Metz; Jose A Diaz; Andrea T Obi; Thomas W Wakefield; Daniel D Myers; Peter K Henke
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

7.  Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells.

Authors:  Barbara Costa; Tanja Eisemann; Jens Strelau; Ingrid Spaan; Andrey Korshunov; Hai-Kun Liu; Peter Bugert; Peter Angel; Heike Peterziel
Journal:  Blood Adv       Date:  2019-04-09

Review 8.  Animal models of venous thrombosis.

Authors:  Hassan Albadawi; Avery A Witting; Yash Pershad; Alex Wallace; Andrew R Fleck; Peter Hoang; Ali Khademhosseini; Rahmi Oklu
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

9.  Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice.

Authors:  Konstantin Stark; Vanessa Philippi; Sven Stockhausen; Johanna Busse; Antonella Antonelli; Meike Miller; Irene Schubert; Parandis Hoseinpour; Sue Chandraratne; Marie-Luise von Brühl; Florian Gaertner; Michael Lorenz; Alessandra Agresti; Raffaele Coletti; Daniel J Antoine; Ralf Heermann; Kirsten Jung; Sven Reese; Iina Laitinen; Markus Schwaiger; Axel Walch; Markus Sperandio; Peter P Nawroth; Christoph Reinhardt; Sven Jäckel; Marco E Bianchi; Steffen Massberg
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

10.  Microengineered Human Vein-Chip Recreates Venous Valve Architecture and Its Contribution to Thrombosis.

Authors:  Navaneeth Krishna Rajeeva Pandian; Brandon K Walther; Rishi Suresh; John P Cooke; Abhishek Jain
Journal:  Small       Date:  2020-11-17       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.